In light of US President Donald Trump’s COVID-19 treatment, the success of monoclonal antibody therapy for the treatment of the disease is being widely discussed. However, is this really a feasible option? In this interview with NewsClick, Dr. Satyajit Rath talks about the limitations of this line of treatment and the future of vaccine development for COVID-19.
COVID-19: Is monoclonal antibody therapy really feasible?
In this interview with NewsClick, Dr. Satyajit Rath talks about the limitations of monoclonal antibody therapy